Blood Pressure as a Cardiovascular Risk Factor | JAMA - Journal of the American Medical Association | 1996 | 635 |
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis | Arteriosclerosis, Thrombosis, and Vascular Biology | 1996 | 366 |
Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? | Arthritis and Rheumatism | 1996 | 262 |
Blood pressure as a cardiovascular risk factor: prevention and treatment | JAMA - Journal of the American Medical Association | 1996 | 258 |
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study | JAMA - Journal of the American Medical Association | 1996 | 228 |
Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study | Clinical Chemistry | 1996 | 150 |
Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990 | Circulation | 1996 | 121 |
Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989 | American Journal of Epidemiology | 1996 | 119 |
Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study | Journal of Nutrition | 1996 | 119 |
Effect of weight on cardiovascular disease | American Journal of Clinical Nutrition | 1996 | 116 |
Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study | Clinical Chemistry | 1996 | 109 |
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study | Atherosclerosis | 1996 | 85 |
Effect of weight on cardiovascular disease | American Journal of Clinical Nutrition | 1996 | 81 |
Exact estimates for a rate ratio | Epidemiology | 1996 | 78 |
The demographics of claudication and the aging of the American population | Vascular Medicine | 1996 | 77 |
Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population | Journal of Nutrition | 1996 | 64 |
The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview | Archives of Internal Medicine | 1996 | 48 |
Systemic side effects of topical beta-adrenergic blockers | Clinical Cardiology | 1996 | 47 |
Left atrial myxoma and acute myocardial infarction. A dangerous duo in the thrombolytic agent era | Chest | 1996 | 42 |
Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience) | American Journal of Cardiology | 1996 | 42 |
Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study | Clinical Chemistry | 1996 | 30 |
Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity | Journal of Electrocardiology | 1996 | 27 |
Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women | American Journal of Cardiology | 1996 | 18 |
Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure | Archives of Internal Medicine | 1996 | 17 |
Doppler diastolic filling indexes in relation to disease states | American Heart Journal | 1996 | 15 |